Spyre Therapeutics Prices $350M Public Offering at $85.00 Per Share

Key Facts

1Spyre Therapeutics announced the pricing of a $350 million public offering of common stock at $85.00 per share.

Spyre Therapeutics announced the pricing of a secondary public offering of its common stock for a total value of $350 million. Investing.com reported that the offering price has been set at $85.00 per share.

The company intends to use the proceeds to raise capital for general corporate purposes or the development of its clinical programs. This offering is significant in size for the biotechnology sector as firms seek to secure necessary funding for their ongoing operations.